These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 7887974

  • 1. Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance.
    Hofmann J, Gekeler V, Ise W, Noller A, Mitterdorfer J, Hofer S, Utz I, Gotwald M, Boer R, Glossmann H.
    Biochem Pharmacol; 1995 Mar 01; 49(5):603-9. PubMed ID: 7887974
    [Abstract] [Full Text] [Related]

  • 2. B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.
    Borchers C, Ulrich WR, Klemm K, Ise W, Gekeler V, Haas S, Schödl A, Conrad J, Przybylski M, Boer R.
    Mol Pharmacol; 1995 Jul 01; 48(1):21-9. PubMed ID: 7623771
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
    Gekeler V, Boer R, Uberall F, Ise W, Schubert C, Utz I, Hofmann J, Sanders KH, Schächtele C, Klemm K, Grunicke H.
    Br J Cancer; 1996 Sep 01; 74(6):897-905. PubMed ID: 8826855
    [Abstract] [Full Text] [Related]

  • 5. Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells.
    Malkhandi J, Ferry DR, Boer R, Gekeler V, Ise W, Kerr DJ.
    Eur J Pharmacol; 1994 Dec 15; 288(1):105-14. PubMed ID: 7705462
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins.
    Chen G, Durán GE, Steger KA, Lacayo NJ, Jaffrézou JP, Dumontet C, Sikic BI.
    J Biol Chem; 1997 Feb 28; 272(9):5974-82. PubMed ID: 9038218
    [Abstract] [Full Text] [Related]

  • 8. MDR hamster cells exhibiting multiple altered gene expression: effects of dexniguldipine-HCl (B859-35), cyclosporin A and buthionine sulfoximine.
    Neumann M, Wilisch A, Diddens H, Probst H, Gekeler V.
    Anticancer Res; 1992 Feb 28; 12(6B):2297-302. PubMed ID: 1284202
    [Abstract] [Full Text] [Related]

  • 9. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E, Demant EJ, Sehested M, Nissen NI.
    Br J Cancer; 1993 Feb 28; 67(2):226-31. PubMed ID: 8094288
    [Abstract] [Full Text] [Related]

  • 10. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
    Rho MC, Hayashi M, Fukami A, Obata R, Sunazuka T, Tomoda H, Komiyama K, Omura S.
    J Antibiot (Tokyo); 2000 Oct 28; 53(10):1201-6. PubMed ID: 11132967
    [Abstract] [Full Text] [Related]

  • 11. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T, Koike K, Ohga T, Kubo T, Wada M, Kohno K, Mori T, Hidaka K, Kuwano M.
    Br J Cancer; 1995 Aug 28; 72(2):418-23. PubMed ID: 7640227
    [Abstract] [Full Text] [Related]

  • 12. Interaction of cytostatics and chemosensitizers with the dexniguldipine binding site on P-glycoprotein.
    Boer R, Ulrich WR, Haas S, Borchers C, Gekeler V, Boss H, Przybylski M, Schödl A.
    Eur J Pharmacol; 1996 Jan 11; 295(2-3):253-60. PubMed ID: 8720592
    [Abstract] [Full Text] [Related]

  • 13. Influence of dexniguldipine-HC1 on rhodamine-123 accumulation in a multidrug-resistant leukaemia cell line: comparison with other chemosensitisers.
    Boer R, Haas S, Schödl A.
    Eur J Cancer; 1994 Jan 11; 30A(8):1117-23. PubMed ID: 7654442
    [Abstract] [Full Text] [Related]

  • 14. Terfenadine (Seldane): a new drug for restoring sensitivity to multidrug resistant cancer cells.
    Hait WN, Gesmonde JF, Murren JR, Yang JM, Chen HX, Reiss M.
    Biochem Pharmacol; 1993 Jan 26; 45(2):401-6. PubMed ID: 8094615
    [Abstract] [Full Text] [Related]

  • 15. Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine.
    Ferry DR, Malkhandi PJ, Russell MA, Kerr DJ.
    Biochem Pharmacol; 1995 Jun 16; 49(12):1851-61. PubMed ID: 7598747
    [Abstract] [Full Text] [Related]

  • 16. Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine.
    Ferry D, Boer R, Callaghan R, Ulrich WR.
    Int J Clin Pharmacol Ther; 2000 Mar 16; 38(3):130-40. PubMed ID: 10739116
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquine.
    Fujita R, Ishikawa M, Takayanagi M, Takayanagi Y, Sasaki K.
    Methods Find Exp Clin Pharmacol; 2000 Jun 16; 22(5):281-4. PubMed ID: 11031728
    [Abstract] [Full Text] [Related]

  • 18. The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts.
    Boven E, Jansen WJ, Hulscher TM, Beijnen JH, van Tellingen O.
    Eur J Cancer; 1999 May 16; 35(5):840-9. PubMed ID: 10505047
    [Abstract] [Full Text] [Related]

  • 19. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
    Toffoli G, Simone F, Gigante M, Boiocchi M.
    Biochem Pharmacol; 1994 Nov 16; 48(10):1871-81. PubMed ID: 7986198
    [Abstract] [Full Text] [Related]

  • 20. Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.
    Germann UA, Shlyakhter D, Mason VS, Zelle RE, Duffy JP, Galullo V, Armistead DM, Saunders JO, Boger J, Harding MW.
    Anticancer Drugs; 1997 Feb 16; 8(2):125-40. PubMed ID: 9073309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.